Pliant Therapeutics


Pliant is advancing drug development programs targeting a range of fibrotic diseases, with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway.

Industries

Employees

51-200

Links


Org chart

Hiring!

Bernard Coulie
President & CEO
Collapse
Hans Hull
Chief Business Officer
Lily Cheung
Chief Human Resources Officer
Minnie Kuo
Chief Development Officer
Christopher Keenan
VP, Investor Relations & Corporate Communications
Fernando Rock
VP, Drug Discovery
Monica Sandberg
VP, Regulatory Affairs
Tim Machajewski
VP, Chemistry
Delphine Imbert
Chief Technology Officer
Diane Ireland
Director Of Facilities And Eh&s

Board & advisors

Hoyoung Huh
Chairman
Suzanne Bruhn
Board Member
Gayle Crowell
Board Member
John Curnutte
Board Of Directors Member
David Pyott
Board Member
Katharine Knobil
Board Member
Thomas McCourt
Board Member
Darren Cline
Board Member
Hal Chapman
Scientific Advisor
Bill DeGrado
Scientific Advisor
Rik Derynck
Scientific Advisor
Bertus Eksteen
Scientific Advisor
Bill Greenlee
Scientific Advisor
Naftali Kaminski
Scientific Advisor
Brian Metcalf
Scientific Advisor
Paul Noble
Scientific Advisor
David Phillips
Scientific Advisor
Dean Sheppard
Scientific Advisor